Induction of apoptosis in lymphoid and myeloid leukemia

[1]  R. Batey,et al.  Targeting XIAP for the treatment of malignancy , 2006, Cell Death and Differentiation.

[2]  S. Agrawal,et al.  Application of XIAP Antisense to Cancer and Other Proliferative Disorders: Development of AEG35156/ GEM®640 , 2005, Annals of the New York Academy of Sciences.

[3]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[4]  G. Pond,et al.  Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells. , 2005, Blood.

[5]  Q. Tong,et al.  Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells , 2005, Cancer Gene Therapy.

[6]  G. Colombo,et al.  Rational design of shepherdin, a novel anticancer agent. , 2005, Cancer cell.

[7]  John Calvin Reed,et al.  Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. , 2005, Cancer research.

[8]  G. Salvesen,et al.  XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs , 2005, The EMBO journal.

[9]  Shaomeng Wang,et al.  Structure-based design of potent, conformationally constrained Smac mimetics. , 2004, Journal of the American Chemical Society.

[10]  M. Sporn,et al.  The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Caspase-Dependent and -Independent Apoptosis in Acute Myelogenous Leukemia , 2004, Cancer Research.

[11]  A. Schimmer.  Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice , 2004, Cancer Research.

[12]  M. Sporn,et al.  c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells , 2004, Cancer Research.

[13]  Xiaodong Wang,et al.  A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death , 2004, Science.

[14]  S. Korsmeyer,et al.  Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.

[15]  Shaomeng Wang,et al.  Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site. , 2004, Journal of Medicinal Chemistry.

[16]  J. C. Wilkinson,et al.  Upstream Regulatory Role for XIAP in Receptor-Mediated Apoptosis , 2004, Molecular and Cellular Biology.

[17]  Saul H Rosenberg,et al.  Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. , 2004, Journal of medicinal chemistry.

[18]  Dajun Yang,et al.  Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. , 2004, Journal of medicinal chemistry.

[19]  D. Bredesen,et al.  Coupling endoplasmic reticulum stress to the cell death program , 2004, Cell Death and Differentiation.

[20]  M. Yuen,et al.  Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. , 2003, Cancer research.

[21]  M. Sporn,et al.  Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL , 2003, Leukemia.

[22]  John Calvin Reed,et al.  Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. , 2003, Journal of medicinal chemistry.

[23]  P. Schultz,et al.  Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction. , 2003, Chemistry & biology.

[24]  V. Dragowska,et al.  Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  A. Venditti,et al.  P‐glycoprotein and BCL‐2 levels predict outcome in adult acute lymphoblastic leukaemia , 2003, British journal of haematology.

[26]  M. Minden,et al.  Bcl-2 and apoptosis in chronic lymphocytic leukemia , 2003, Current treatment options in oncology.

[27]  S. Srinivasula,et al.  Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.

[28]  M. Sporn,et al.  An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[29]  Alessandra Giodini,et al.  Regulation of microtubule stability and mitotic progression by survivin. , 2002, Cancer research.

[30]  M. Minden,et al.  Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view. , 2001, Blood.

[31]  R. Liddington,et al.  Structural Basis for the Inhibition of Caspase-3 by XIAP , 2001, Cell.

[32]  S. Srinivasula,et al.  Structural Basis of Caspase-7 Inhibition by XIAP , 2001, Cell.

[33]  Young Chul Park,et al.  Structural Basis of Caspase Inhibition by XIAP Differential Roles of the Linker versus the BIR Domain , 2001, Cell.

[34]  D. Fennell,et al.  In vivo suppression of Bcl‐XL expression facilitates chemotherapy‐induced leukaemia cell death in a SCID/NOD‐Hu model , 2001, British journal of haematology.

[35]  Stephen W. Fesik,et al.  NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP* , 2000, The Journal of Biological Chemistry.

[36]  A Sankar,et al.  The three-dimensional solution structure and dynamic properties of the human FADD death domain. , 2000, Journal of molecular biology.

[37]  B. Dörken,et al.  Constitutive expression levels of CD95 and Bcl‐2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia , 2000, British journal of haematology.

[38]  S. Srinivasula,et al.  Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Green,et al.  Granzyme B Short-Circuits the Need for Caspase 8 Activity during Granule-Mediated Cytotoxic T-Lymphocyte Killing by Directly Cleaving Bid , 2000, Molecular and Cellular Biology.

[40]  Mark P Mattson,et al.  Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders , 2000, Trends in Neurosciences.

[41]  S. Strom,et al.  Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.

[42]  M. Sporn,et al.  The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[43]  Stephen W. Fesik,et al.  NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP , 1999, Nature.

[44]  GS Salomons,et al.  Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome , 1999, Leukemia.

[45]  J C Reed,et al.  Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases , 1999, The EMBO journal.

[46]  G. Núñez,et al.  Role of cytochrome c and dATP/ATP hydrolysis in Apaf‐1‐mediated caspase‐9 activation and apoptosis , 1999, The EMBO journal.

[47]  S. Srinivasula,et al.  Cytochrome c and dATP-mediated Oligomerization of Apaf-1 Is a Prerequisite for Procaspase-9 Activation* , 1999, The Journal of Biological Chemistry.

[48]  X. Liu,et al.  An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9* , 1999, The Journal of Biological Chemistry.

[49]  D. Baltimore,et al.  Dissecting Fas signaling with an altered-specificity death-domain mutant: requirement of FADD binding for apoptosis but not Jun N-terminal kinase activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  C. Rauch,et al.  Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.

[51]  S. Srinivasula,et al.  Cascades of Mammalian Caspase Activation in the YeastSaccharomyces cerevisiae * , 1999, The Journal of Biological Chemistry.

[52]  M. Sporn,et al.  A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. , 1999, Cancer research.

[53]  Fengzhi Li,et al.  Control of apoptosis and mitotic spindle checkpoint by survivin , 1998, Nature.

[54]  J C Reed,et al.  Pro-caspase-3 Is a Major Physiologic Target of Caspase-8* , 1998, The Journal of Biological Chemistry.

[55]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[56]  V. Cryns,et al.  Proteases to die for. , 1998, Genes & development.

[57]  John Calvin Reed,et al.  Granzyme Release and Caspase Activation in Activated Human T-Lymphocytes* , 1998, The Journal of Biological Chemistry.

[58]  S. Tura,et al.  High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate , 1997, Leukemia.

[59]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[60]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[61]  C. Wuchter,et al.  Differences in the expression pattern of apoptosis-related molecules between childhood and adult de novo acute myeloid leukemia. , 2004, Haematologica.

[62]  Clemencia Pinilla,et al.  Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. , 2004, Cancer cell.

[63]  E. Rieber,et al.  Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell. , 2003, Molecular biology of the cell.

[64]  G M Cohen,et al.  XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis , 2002, Cell Death and Differentiation.

[65]  J. Jelinek,et al.  TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors , 2002, Leukemia.

[66]  L. Naumovski,et al.  BCL-2 expression does not correlate with patient outcome in pediatric acute myelogenous leukemia , 1998 .

[67]  F. Keith,et al.  Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C. , 1995, Leukemia.